Historical record - last NADAC effective date: 7/17/2024
Product Information
MOMETASONE FUROATE 0.1% OINT is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2236 per GM under NDC 68462022555. Its NADAC has been published 558 times since Nov 28, 2013.
FDA first approved this application on May 28, 2008.
Strength
1 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462022555
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
7/17/2024
Active Ingredients
MOMETASONE FUROATEApproval Type
Generic (ANDA)
FDA Application
ANDA078571FDA Approved
5/28/2008
On Market Since
5/28/2008
Pharmacological Classes
Price Statistics
The NADAC for MOMETASONE FUROATE 0.1% OINT has been published 558 times since Nov 28, 2013, and over the history we have for it it has declined 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2236 per GM |
|---|---|
| All-time high | $0.3588 (Aug 16, 2023) |
| All-time low | $0.1552 (Jan 18, 2023) |
| Median price | $0.2117 |
| Average price | $0.2198 |
| Largest weekly change | +45.4% (Mar 22, 2023) |
| Weeks tracked | 558 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-37.7%
5Y
+27.8%
All
-7.0%
Last surveyed Jul 31, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MOMETASONE FUROATE 0.1% OINT?
The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% OINT, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2236 per GM (NDC 68462022555), effective Jul 31, 2024.
How has the price of MOMETASONE FUROATE 0.1% OINT changed over time?
Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% OINT has declined 7.0%. It has been tracked across 558 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% OINT?
Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% OINT has ranged from a low of $0.1552 (Jan 18, 2023) to a high of $0.3588 (Aug 16, 2023), with a median of $0.2117 per GM.
Are there cheaper alternatives to MOMETASONE FUROATE 0.1% OINT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MOMETASONE FUROATE 0.1% OINT in a comparable dosage form, but none are currently priced below it.
Who manufactures MOMETASONE FUROATE 0.1% OINT?
MOMETASONE FUROATE 0.1% OINT (NDC 68462022555) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.